Skip to main content Help with accessibility Skip to main navigation

NALDEMEDINE tablets (Rizmoic®▼) for the treatment of opioid-induced constipation

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 22 - Oct - 2020
Body System:
Green
NALDEMEDINE tablets (Rizmoic®▼) for the treatment of opioid-induced constipation

The Pan Mersey Area Prescribing Committee recommends the prescribing of NALDEMEDINE tablets (Rizmoic®▼) for the treatment of opioid-induced constipation in accordance with NICE TA651.